Infectious Diseases
Microbiology
Tomàs Pumarola Suñé
Researchers
Dr. Antònia Andreu Domingo, Dr. Andres Antón Pagarolas , Dr. Rosa M.Bartolomé Comas, Dr. Estrella Caballero Requero , Dr. Gema Codina Grau, Dr. Juliana Esperalba Esquerra, Dr. Juan José González López, Dr. M. Nieves Larrosa Escartín , Dr. M. Teresa Martín Gómez, Dr. Mayli Lung Suarez, Dr. Elena Sulleiro Igual, Dr. M. Teresa Tórtola Fernández, Dr. Mateu Espasa, Dr. Marc Torrent Burgas , Dra. Virginia Rodriguez, Dra. Glória Roig, Dra. Belén Viñado, Dra. Mercè Locutura, Dra. Rosa Juvé , Nuria Piedra Carrasco, Antoni Mirambell Viñas , Laura Gimferrer Arriaga , Cristina Andrés Vergés
SUMMARY
We are developing several projects that fall within the following thematic lines of work: epidemiology and antimicrobial resistance, sexually transmitted diseases, respiratory virus, viral and fungal infection in immunosuppressed patients, cystic fibrosis, foodborne infections, tuberculosis and international health. We collaborate with other laboratories of microbiology, healthcare services, national and international organizations as well as various research Spanish networks of the Carlos III Health Institute. Additionally, the Microbiology Research Group acts as a Reference Laboratory for the Public Administration on the study of community outbreaks of foodborne infections, sexually transmitted diseases and screening of infection by human papillomavirus. It is also a Supranational Reference Laboratory (WHO) for the quality control for antibiotic sensitivity testing of mycobacteria and the Reference Laboratory of the Spanish Network of Tuberculosis Laboratories for the external quality control for antibiotic sensitivity testing for mycobacteria.
PUBLICATIONS
- Molina I, Gómez i Prat J, Salvador F, Treviño B, Sulleiro E, Serre N, Pou D, Roure S, Cabezos J, Valerio L, Blanco-Grau A, Sánchez-Montalvá A, Vidal X, Pahissa A.Randomized trial of posaconazole and benznidazole for chronic Chagas’ disease. N Engl J Med. 2014. 15;370(20):1899-908
- González-López JJ, Piedra-Carrasco N, Salvador F, Rodríguez V, Sánchez-Montalvá A, Planes AM, Molina I, Larrosa MN. ESBL-producing Salmonella enterica serovar Typhi in traveler returning from Guatemala to Spain. Emerg Infect Dis. 2014;20(11):1918-20
- Oteo J, González-López JJ, Ortega A, Quintero-Zárate JN, Bou G, Cercenado E, Conejo MC, Martínez-Martínez L, Navarro F, Oliver A, Bartolomé RM, Campos J; Spanish Network for Research in Infectious Diseases (REIPI). Inhibitor-resistant TEM- and OXA-1-producing Escherichia coli isolates resistant to amoxicillin-clavulanate are more clonal and possess lower virulence gene content than susceptible clinical isolates. Antimicrob Agents Chemother. 2014;58(7):3874-81
- Salvador F, Sulleiro E, Sánchez-Montalvá A, Saugar JM, Rodríguez E, Pahissa A, Molina I. Usefulness of Strongyloides stercoralis serology in the management of patients with eosinophilia. Am J Trop Med Hyg. 2014 ;90(5):830-4.
- Pérez-Llarena FJ, Zamorano L, Kerff F, Beceiro A, García P, Miró E, Larrosa N, Gómez-Bertomeu F, Méndez JA, González-López JJ, Oliver A, Galleni M, Navarro F, Bou G. Genetic and kinetic characterization of the novel AmpC β-lactamases DHA-6 and DHA-7. Antimicrob Agents Chemother. 2014;58(11):6544-9
MAIN RESEARCH PROJECTS
View- RAIS: Scalable, point-of-care and label free microarray platform for rapid detection of Sepsis
IP: Bartolomé Comas, Rosa María
Entitat Finançadora: European Commission
Referència: RAIS_H2020-H&ICT2014
Finançament: 411.875,00 €
Durada: des del 2015 al 2017 - Factores virológicos y del huésped asociados a una mayor gravedad de la infección por el virus respiratorio sincitial (VRS)
IP: Pumarola Suñé, Tomàs
Entitat Finançadora: Fondo de Investigación Sanitaria
Referència: PI14/01838
Finançament: 116.765,00 €
Durada: des del 2015 al 2017 - Neisseria gonorrhoeae: Monitorización de la sensibilidad antimicrobiana, estudio de la dinámica poblacional y caracterización molecular de las resistencias
IP: Andreu Domingo, Antònia
Entitat Finançadora: Fondo de Investigación Sanitaria
Referència: PI12/01808
Finançament: 50.215,00 €
Durada: des del 2013 al 2016 - Development of a universal inFLUenza vaccine based on Tandem CORE technology (FLUTCORE) Grant Agreement nº 602437
IP: Campins Martí, Magda
Entitat Finançadora: European Commission
Referència: FLUTCORE_FP7HEALTH2013
Finançament: 81.420,00 €
Durada: des del 2013 al 2017 - Penetración de los antibióticos en la infección ósea en el esqueleto inmaduro. Estudio farmacocinético en el modelo animal
IP: Soler Palacin, Pere
Entitat Finançadora: Fondo de Investigación Sanitaria
Referència: PI13/00877
Finançament: 58.685,00 €
Durada: des del 2014 al 2016